Clindac-A Gel 1% Pharmaceutical
| Features | |
| Also known as | Clindamycin 2-phosphate |
| Blood pressure | No significant impact |
| Chemical name | Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-О±-D-galacto-octopyranoside 2-(dihydrogen phosphate) |
| Dosage (medical) | 150-450 mg orally every 6 hours or 600-900 mg IV every 8 hours, depending on the severity of the infection |
| Dosage (sports) | Not applicable |
| Effects | Inhibits bacterial protein synthesis, leading to the death of bacteria |
| Formula | C18H34ClN2O8PS |
| Half-life | 2.4 hours |
| Hepatotoxicity | Rare, but cases of hepatitis and liver dysfunction have been reported |
| Lab Test | Monitoring of liver and renal functions may be required |
| Main action | Antimicrobial |
| Side effects | Nausea, vomiting, diarrhea, abdominal pain, rash, itching, and potential for pseudomembranous colitis |
| Storage conditions | Store at 20В° to 25В°C (68В° to 77В°F) |
| Substance class | Antibiotic |
| Trade name | Cleocin |
| Use in sports | Not typically used in sports |
| Water Retention | No significant effect |
| Manufacturer | Pharmaceutical |